# Top 30 Prioritized Location Analysis

> *Comprehensive Ranking and Analysis of Global Expansion Targets*

---

## Overview

This document presents the detailed analysis and prioritized ranking of 30 target locations for Transformational Epicenter expansion. Each location has been evaluated using the comprehensive 100-point scoring methodology and is assigned to an expansion phase based on strategic fit, risk profile, and market opportunity.

---

## Priority Ranking Summary

### Complete 30-Location Ranking

| Rank | Location | Region | Score | Phase | Tier | Primary Offering |
|------|----------|--------|-------|-------|------|------------------|
| 1 | Quintana Roo, Mexico | Americas | 94 | 1 | Flagship | Ibogaine + Full Integration |
| 2 | Baja California, Mexico | Americas | 87 | 1 | Regional | Ibogaine (US West Proximity) |
| 3 | Alentejo, Portugal | Europe | 86 | 1 | Flagship | Ibogaine + European Hub |
| 4 | Jamaica (Montego Bay) | Caribbean | 85 | 1 | Regional | Psilocybin + Wellness |
| 5 | The Bahamas (Nassau/Exumas) | Caribbean | 84 | 2 | Regional | Ibogaine + Psilocybin |
| 6 | Costa Rica (Guanacaste) | Americas | 83 | 1 | Regional | Ayahuasca + Bio-optimization |
| 7 | Singapore | Asia-Pacific | 83 | 3 | Regional | Bio-optimization + Medical |
| 8 | Netherlands (Amsterdam) | Europe | 82 | 2 | Satellite | Psilocybin Truffles + Bio |
| 9 | South Africa (Cape Town) | Africa | 82 | 3 | Flagship | Ibogaine + Safari Wellness |
| 10 | Thailand (Koh Samui) | Asia-Pacific | 81 | 3 | Regional | Wellness + Bio-optimization |
| 11 | Switzerland (Zurich) | Europe | 81 | 4 | Regional | Medical + Longevity |
| 12 | New Zealand (Queenstown) | Oceania | 80 | 3 | Regional | Psilocybin (evolving) + Wellness |
| 13 | St. Vincent & Grenadines | Caribbean | 79 | 2 | Satellite | Psilocybin + Luxury |
| 14 | UAE (Dubai) | Middle East | 79 | 3 | Regional | Bio-optimization + Medical |
| 15 | Australia (Byron Bay) | Oceania | 79 | 4 | Regional | Psilocybin (evolving) + Wellness |
| 16 | Cayman Islands | Caribbean | 78 | 2 | Satellite | Medical Wellness + Bio |
| 17 | Bali, Indonesia | Asia-Pacific | 78 | 3 | Regional | Wellness + Integration |
| 18 | Canada (British Columbia) | Americas | 78 | 4 | Regional | Psilocybin (regulated) + Wellness |
| 19 | Peru (Sacred Valley) | Americas | 77 | 2 | Satellite | Ayahuasca + Traditional |
| 20 | Maldives | Indian Ocean | 77 | 4 | Satellite | Luxury Wellness + Integration |
| 21 | Spain (Ibiza) | Europe | 76 | 3 | Satellite | Wellness + Integration |
| 22 | Japan (Okinawa) | Asia | 76 | 4 | Satellite | Wellness + Bio-optimization |
| 23 | Turks & Caicos | Caribbean | 76 | 4 | Satellite | Luxury Wellness |
| 24 | Brazil (Bahia) | Americas | 75 | 2 | Regional | Ayahuasca + Wellness |
| 25 | Czech Republic (Prague) | Europe | 75 | 4 | Satellite | Psilocybin + European Hub |
| 26 | Morocco (Marrakech) | Africa | 74 | 3 | Satellite | Wellness + Bio-optimization |
| 27 | Antigua | Caribbean | 74 | 4 | Satellite | Wellness + Caribbean Hub |
| 28 | Trinidad & Tobago | Caribbean | 73 | 2 | Satellite | Ibogaine (emerging) |
| 29 | Seychelles | Indian Ocean | 73 | 4 | Satellite | Luxury Wellness |
| 30 | Fiji | Pacific | 72 | 4 | Satellite | Wellness + Pacific Hub |

---

## Phase 1: Foundation Markets (Locations 1-5)

### Location #1: Quintana Roo, Mexico

**Overall Score: 94/100** | **Tier: Flagship** | **Investment: $50-60M**

```
┌─────────────────────────────────────────────────────────────────────────────┐
│                     #1 QUINTANA ROO, MEXICO                                  │
│                     FLAGSHIP LOCATION                                        │
├─────────────────────────────────────────────────────────────────────────────┤
│                                                                              │
│  SCORING BREAKDOWN:                                                          │
│  ├─ Regulatory Environment:     23/25  (Ibogaine unregulated, stable)       │
│  ├─ Medical Infrastructure:     19/20  (JCI hospitals, excellent access)    │
│  ├─ Market Accessibility:       15/15  (500+ daily flights, visa-free)      │
│  ├─ Real Estate Viability:      13/15  (Available but appreciating fast)    │
│  ├─ Talent Availability:        10/10  (Strong medical/hospitality pool)    │
│  ├─ Climate & Environment:       9/10  (Year-round tropical, hurricane risk)│
│  └─ Operational Costs:           5/5   (Favorable labor and taxes)          │
│                                                                              │
│  TOTAL SCORE: 94/100                                                         │
│                                                                              │
└─────────────────────────────────────────────────────────────────────────────┘
```

**Why #1 Priority:**
- Ibogaine is fully unregulated - no legal barriers to core offering
- JCI-accredited hospitals within 15 minutes (Galenia, Amerimed, Hospiten)
- Cancun International Airport: 500+ daily flights, 40+ US cities direct
- Level 2 travel advisory (same as France, UK, Italy)
- Established medical tourism infrastructure with US/European-trained physicians
- Year-round tropical climate ideal for healing and recovery
- Strong bilingual workforce in hospitality and medical sectors

**Specific Location Recommendations:**
| Area | Pros | Cons | Recommendation |
|------|------|------|----------------|
| Playa del Carmen | Central location, excellent amenities | Tourist-heavy | ✅ Top Choice |
| Puerto Morelos | Quieter, authentic, good hospital access | Smaller community | ✅ Strong Alternative |
| Akumal | Tranquil, natural beauty | Further from airport | ⚠️ Consider |
| Tulum | Wellness reputation | Infrastructure issues, airport problems | ❌ Avoid |

**Key Hospitals:**
- **Galenia Hospital**: Level 5, only hospital of its category in Quintana Roo
- **Hospital Amerimed Cancun**: JCI-accredited since 2018
- **Hospiten Cancun**: 1,300+ physicians, full cardiac capabilities

**Risk Factors:**
- Hurricane season (June-November) - manageable with protocols
- Real estate appreciation (14.68% YoY) - act quickly on acquisition
- Tourism terrorism advisory (2025) - monitor but not disqualifying

**Investment Estimate:**
| Component | Cost Range |
|-----------|------------|
| Land/Property Acquisition | $3-5M |
| Construction/Renovation | $20-30M |
| Medical Equipment | $2-3M |
| FF&E (Furniture, Fixtures) | $3-5M |
| Pre-opening Costs | $2-3M |
| Working Capital | $5-7M |
| Contingency (15%) | $5-8M |
| **Total** | **$40-61M** |

---

### Location #2: Baja California, Mexico

**Overall Score: 87/100** | **Tier: Regional Hub** | **Investment: $25-35M**

```
┌─────────────────────────────────────────────────────────────────────────────┐
│                     #2 BAJA CALIFORNIA, MEXICO                               │
│                     REGIONAL HUB                                             │
├─────────────────────────────────────────────────────────────────────────────┤
│                                                                              │
│  SCORING BREAKDOWN:                                                          │
│  ├─ Regulatory Environment:     23/25  (Ibogaine unregulated)               │
│  ├─ Medical Infrastructure:     16/20  (Good hospitals, SD backup)          │
│  ├─ Market Accessibility:       14/15  (20 min from San Diego)              │
│  ├─ Real Estate Viability:      13/15  (Lower costs than Q. Roo)            │
│  ├─ Talent Availability:         9/10  (Bilingual workforce)                │
│  ├─ Climate & Environment:       7/10  (Good, but desert climate)           │
│  └─ Operational Costs:           5/5   (Very favorable)                     │
│                                                                              │
│  TOTAL SCORE: 87/100                                                         │
│                                                                              │
└─────────────────────────────────────────────────────────────────────────────┘
```

**Why #2 Priority:**
- 20 minutes from San Diego - unmatched US proximity
- 10+ year operational history for ibogaine clinics
- Can leverage San Diego hospitals for extreme emergencies
- Lower real estate costs than Quintana Roo
- Established clinic models to learn from (6+ existing operations)

**Key Considerations:**
- Level 3 travel advisory - requires client education and careful site selection
- UK advises caution - may impact European client willingness
- Competitor saturation - differentiation critical

**Specific Location Recommendations:**
| Area | Pros | Cons | Recommendation |
|------|------|------|----------------|
| Rosarito Beach | Coastal, established clinics, gated communities | Level 3 advisory | ✅ Best Option |
| Ensenada | Wine country, upscale | Further from border | ✅ Consider |
| Tijuana Border Zone | Hospital access | Security concerns | ❌ Avoid |

---

### Location #3: Alentejo, Portugal

**Overall Score: 86/100** | **Tier: Flagship (European HQ)** | **Investment: $40-50M**

```
┌─────────────────────────────────────────────────────────────────────────────┐
│                     #3 ALENTEJO, PORTUGAL                                    │
│                     EUROPEAN FLAGSHIP                                        │
├─────────────────────────────────────────────────────────────────────────────┤
│                                                                              │
│  SCORING BREAKDOWN:                                                          │
│  ├─ Regulatory Environment:     20/25  (Decriminalized, clinics operate)    │
│  ├─ Medical Infrastructure:     17/20  (EU standards, good hospitals)       │
│  ├─ Market Accessibility:       13/15  (Excellent EU access)                │
│  ├─ Real Estate Viability:      12/15  (Rising prices, still available)     │
│  ├─ Talent Availability:         9/10  (EU talent pool)                     │
│  ├─ Climate & Environment:       9/10  (Mediterranean, minimal disasters)   │
│  └─ Operational Costs:           6/5   (Higher costs than Americas)         │
│                                                                              │
│  TOTAL SCORE: 86/100                                                         │
│                                                                              │
└─────────────────────────────────────────────────────────────────────────────┘
```

**Why #3 Priority:**
- Decriminalized framework with operational ibogaine clinics (Tabula Rasa model)
- Schengen zone access for all EU citizens
- Excellent connectivity to London, Northern Europe, Middle East
- High medical standards with EU compliance
- Established legal precedent for plant medicine operations
- Sophisticated, wealthy European client base

**Key Considerations:**
- Decriminalized ≠ Legal - requires careful legal structuring
- Higher operating costs than Latin America
- Real estate prices rising rapidly (15.8% YoY in 2025)

**Specific Location Recommendations:**
| Area | Pros | Cons | Recommendation |
|------|------|------|----------------|
| Alentejo Interior | Tranquil, authentic, lower costs | Remote from Lisbon | ✅ Best Option |
| Comporta | Luxury positioning, beach access | Very expensive | ⚠️ High-end only |
| Sintra | Historical, beautiful | Tourist traffic | ⚠️ Consider |

---

### Location #4: Jamaica (Montego Bay)

**Overall Score: 85/100** | **Tier: Regional Hub** | **Investment: $25-35M**

```
┌─────────────────────────────────────────────────────────────────────────────┐
│                     #4 JAMAICA (MONTEGO BAY)                                 │
│                     PSILOCYBIN HUB                                           │
├─────────────────────────────────────────────────────────────────────────────┤
│                                                                              │
│  SCORING BREAKDOWN:                                                          │
│  ├─ Regulatory Environment:     22/25  (Psilocybin FULLY LEGAL)             │
│  ├─ Medical Infrastructure:     14/20  (Adequate, not excellent)            │
│  ├─ Market Accessibility:       14/15  (Direct US/UK flights)               │
│  ├─ Real Estate Viability:      13/15  (Available, reasonable)              │
│  ├─ Talent Availability:         8/10  (Hospitality strong, medical limited)│
│  ├─ Climate & Environment:       9/10  (Caribbean paradise, hurricane risk) │
│  └─ Operational Costs:           5/5   (Favorable)                          │
│                                                                              │
│  TOTAL SCORE: 85/100                                                         │
│                                                                              │
└─────────────────────────────────────────────────────────────────────────────┘
```

**Why #4 Priority:**
- Psilocybin is FULLY LEGAL (not grey area, not decriminalized - LEGAL)
- Government actively promoting psychedelic wellness industry
- English-speaking with established tourism infrastructure
- Direct flights from major US and UK cities
- Unique positioning for psilocybin-focused programs

**Key Considerations:**
- Medical infrastructure inferior to Mexico - requires enhanced on-site capability
- Hurricane exposure (June-November)
- Not established for ibogaine - psilocybin-only positioning

**Existing Model Validation:**
| Center | Features | Validation |
|--------|----------|------------|
| Atman Retreat | 18th-century property, hospital partnership, NYU advisors | Premium positioning works |
| ONE Retreats | 7-day programs, $4,500, farm-to-table | Mid-market viable |
| Evolution Retreats | Tensing Pen (highest-rated resort), cliffside | Ultra-luxury validated |

---

### Location #5: Costa Rica (Guanacaste)

**Overall Score: 83/100** | **Tier: Regional Hub** | **Investment: $20-30M**

```
┌─────────────────────────────────────────────────────────────────────────────┐
│                     #5 COSTA RICA (GUANACASTE)                               │
│                     AYAHUASCA + BIO-OPTIMIZATION                             │
├─────────────────────────────────────────────────────────────────────────────┤
│                                                                              │
│  SCORING BREAKDOWN:                                                          │
│  ├─ Regulatory Environment:     17/25  (Grey area, Rythmia model exists)    │
│  ├─ Medical Infrastructure:     16/20  (JCI hospitals in San Jose)          │
│  ├─ Market Accessibility:       13/15  (Good US/Canada connections)         │
│  ├─ Real Estate Viability:      12/15  (Appreciating rapidly)               │
│  ├─ Talent Availability:         9/10  (Strong wellness community)          │
│  ├─ Climate & Environment:      10/10  (Blue Zone, exceptional nature)      │
│  └─ Operational Costs:           6/5   (Moderate)                           │
│                                                                              │
│  TOTAL SCORE: 83/100                                                         │
│                                                                              │
└─────────────────────────────────────────────────────────────────────────────┘
```

**Why #5 Priority:**
- Rythmia has proven the licensed ayahuasca model is possible
- Nicoya Peninsula is a certified Blue Zone (longevity research hub)
- Exceptional natural environment and climate
- Political stability and safety (Level 1 advisory)
- Strong wellness tourism reputation

**Key Considerations:**
- NOT recommended for ibogaine - legal grey area too risky
- Requires Ministry of Health licensing pathway (Rythmia model)
- High wellness competition - differentiation essential

---

## Phase 2: Market Expansion (Locations 6-12)

### Location #6: The Bahamas (Nassau/Exumas)

**Overall Score: 84/100** | **Tier: Regional Hub** | **Investment: $30-40M**

**Key Differentiator:** Only Caribbean location where BOTH psilocybin AND ibogaine are accessible. Unique multi-modality positioning.

**Scoring Highlights:**
- Regulatory: 21/25 - Both substances accessible
- Medical: 14/20 - Limited but adequate
- Accessibility: 14/15 - Short flights from Florida
- Real Estate: 11/15 - Premium pricing

**Strategic Value:** Serves US East Coast with combined ibogaine + psilocybin offering unavailable elsewhere in the region.

---

### Location #7: St. Vincent & Grenadines

**Overall Score: 79/100** | **Tier: Satellite** | **Investment: $15-20M**

**Key Differentiator:** Emerging psilocybin jurisdiction with ultra-luxury positioning potential in pristine Caribbean setting.

**Scoring Highlights:**
- Regulatory: 18/25 - Psilocybin accessible
- Medical: 12/20 - Limited infrastructure
- Accessibility: 12/15 - Improving connections
- Climate: 10/10 - Exceptional

**Strategic Value:** Ultra-exclusive positioning for discerning clients seeking privacy and pristine environment.

---

### Location #8: Netherlands (Amsterdam)

**Overall Score: 82/100** | **Tier: Satellite** | **Investment: $20-25M**

**Key Differentiator:** Legal psilocybin truffles with world-class infrastructure and European accessibility.

**Scoring Highlights:**
- Regulatory: 18/25 - Truffles legal, no medical claims allowed
- Medical: 18/20 - Excellent infrastructure
- Accessibility: 15/15 - Major European hub
- Operational: 2/5 - High costs

**Strategic Value:** European bio-optimization hub with legal psilocybin truffle integration.

---

### Location #9: Cayman Islands

**Overall Score: 78/100** | **Tier: Satellite** | **Investment: $25-30M**

**Key Differentiator:** Tax-efficient jurisdiction with strong financial services infrastructure, ideal for UHNW clients.

**Strategic Value:** Premium positioning for financial industry executives and high-net-worth individuals from Americas and UK.

---

### Location #10: Peru (Sacred Valley)

**Overall Score: 77/100** | **Tier: Satellite** | **Investment: $10-15M**

**Key Differentiator:** Authentic ayahuasca tradition with legal protection for traditional use.

**Scoring Highlights:**
- Regulatory: 19/25 - Ayahuasca legally protected
- Medical: 10/20 - Remote location challenges
- Authenticity: Highest - Traditional shamanic lineage

**Strategic Value:** Partnership model with established centers for clients seeking authentic traditional medicine experience.

---

### Location #11: Brazil (Bahia)

**Overall Score: 75/100** | **Tier: Regional** | **Investment: $20-25M**

**Key Differentiator:** Legal ayahuasca (Santo Daime tradition) with emerging wellness infrastructure.

**Strategic Value:** Serves South American UHNW market and global clients seeking Brazilian wellness experience.

---

### Location #12: Trinidad & Tobago

**Overall Score: 73/100** | **Tier: Satellite** | **Investment: $12-18M**

**Key Differentiator:** Emerging ibogaine jurisdiction with Caribbean positioning.

**Strategic Value:** Early-mover advantage in developing market with proximity to South American oil wealth.

---

## Phase 3: Global Network (Locations 13-20)

### Location #13: Thailand (Koh Samui)

**Overall Score: 81/100** | **Tier: Regional** | **Investment: $25-30M**

**Key Differentiator:** Medical tourism leader with evolving psilocybin regulations and exceptional wellness infrastructure.

**Scoring Highlights:**
- Regulatory: 14/25 - Research framework emerging, wellness legal
- Medical: 18/20 - Excellent medical tourism infrastructure
- Accessibility: 14/15 - Major Asian hub
- Value: 5/5 - Excellent cost structure

**Strategic Value:** Bio-optimization focus for Asia-Pacific market with future plant medicine potential.

---

### Location #14: Bali, Indonesia

**Overall Score: 78/100** | **Tier: Regional** | **Investment: $20-25M**

**Key Differentiator:** Global wellness destination with spiritual culture and strong talent pool.

**Critical Note:** Strict drug laws - NO plant medicine operations possible. Bio-optimization + integration only.

**Strategic Value:** Wellness and integration hub serving Australia, Asia, and global wellness seekers.

---

### Location #15: New Zealand (Queenstown)

**Overall Score: 80/100** | **Tier: Regional** | **Investment: $30-35M**

**Key Differentiator:** Psilocybin regulations evolving with clinical trials active; pristine natural environment.

**Strategic Value:** Oceania hub with potential for regulated psilocybin services as framework develops.

---

### Location #16: Spain (Ibiza)

**Overall Score: 76/100** | **Tier: Satellite** | **Investment: $20-25M**

**Key Differentiator:** European jet-set destination with established wellness infrastructure.

**Note:** Plant medicine grey area - wellness and integration focus.

**Strategic Value:** European luxury wellness satellite capturing seasonal Mediterranean demand.

---

### Location #17: Morocco (Marrakech)

**Overall Score: 74/100** | **Tier: Satellite** | **Investment: $15-20M**

**Key Differentiator:** European proximity with North African mystique and luxury hospitality tradition.

**Note:** No plant medicine framework - bio-optimization and wellness only.

**Strategic Value:** Wellness tourism hub serving European and Middle Eastern clients.

---

### Location #18: South Africa (Cape Town)

**Overall Score: 82/100** | **Tier: Flagship** | **Investment: $35-45M**

**Key Differentiator:** Ibogaine is LEGAL and operational with safari wellness combination potential.

**Scoring Highlights:**
- Regulatory: 21/25 - Ibogaine legal, operational clinics exist
- Medical: 16/20 - Good private healthcare
- Environment: 10/10 - Exceptional natural beauty
- Accessibility: 12/15 - Further from key markets

**Strategic Value:** African flagship serving Europe and Africa with unique ibogaine + safari experience.

---

### Location #19: UAE (Dubai)

**Overall Score: 79/100** | **Tier: Regional** | **Investment: $40-50M**

**Key Differentiator:** UHNW concentration with world-class infrastructure.

**Critical Note:** Strict drug laws - NO plant medicine possible. Bio-optimization and medical longevity only.

**Scoring Highlights:**
- Medical: 19/20 - World-class healthcare
- Accessibility: 15/15 - Global hub
- Real Estate: 10/15 - Very expensive
- Regulatory: 8/25 - No plant medicine

**Strategic Value:** Bio-optimization and medical longevity hub for Middle East, Asia, and global UHNW.

---

### Location #20: Singapore

**Overall Score: 83/100** | **Tier: Regional** | **Investment: $45-55M**

**Key Differentiator:** Asia-Pacific financial hub with world-class medical infrastructure.

**Critical Note:** Severe drug laws - NO plant medicine possible. Bio-optimization and medical only.

**Scoring Highlights:**
- Medical: 20/20 - World-class
- Accessibility: 15/15 - Major Asian hub
- Regulatory: 5/25 - No plant medicine
- Operational: 2/5 - Very high costs

**Strategic Value:** Premium bio-optimization and medical longevity for Asia-Pacific UHNW market.

---

## Phase 4: Market Saturation (Locations 21-30)

### Locations 21-30 Summary

| Rank | Location | Score | Primary Focus | Target Market |
|------|----------|-------|---------------|---------------|
| 21 | Maldives | 77 | Luxury Wellness + Integration | Global UHNW |
| 22 | Switzerland (Zurich) | 81 | Medical + Longevity | European UHNW |
| 23 | Japan (Okinawa) | 76 | Wellness + Bio-optimization | Asia UHNW |
| 24 | Australia (Byron Bay) | 79 | Psilocybin (evolving) + Wellness | Oceania |
| 25 | Canada (British Columbia) | 78 | Psilocybin (regulated) + Wellness | North America |
| 26 | Czech Republic (Prague) | 75 | Psilocybin + European Hub | Central Europe |
| 27 | Antigua | 74 | Wellness + Caribbean Hub | Americas |
| 28 | Turks & Caicos | 76 | Luxury Wellness | US East Coast |
| 29 | Seychelles | 73 | Luxury Wellness | Africa, Middle East |
| 30 | Fiji | 72 | Wellness + Pacific Hub | Oceania, Asia |

---

## Comparative Analysis Matrix

### Regulatory Comparison

| Location | Ibogaine | Psilocybin | Ayahuasca | Ketamine | Total Reg Score |
|----------|----------|------------|-----------|----------|-----------------|
| Quintana Roo, MX | ✅ Legal | ❌ | ❌ | ✅ Medical | 23/25 |
| Baja California, MX | ✅ Legal | ❌ | ❌ | ✅ Medical | 23/25 |
| Jamaica | ❌ | ✅ Legal | ❌ | ⚠️ | 22/25 |
| Bahamas | ✅ Accessible | ✅ Legal | ❌ | ⚠️ | 21/25 |
| South Africa | ✅ Legal | ❌ | ❌ | ✅ Medical | 21/25 |
| Portugal | ✅ Decrim | ❌ | ❌ | ✅ Medical | 20/25 |
| Peru | ❌ | ❌ | ✅ Legal | ❌ | 19/25 |
| Netherlands | ⚠️ Smart shops | ✅ Truffles | ❌ | ⚠️ | 18/25 |
| Costa Rica | ❌ | ❌ | ⚠️ Grey | ⚠️ | 17/25 |

### Market Access Comparison

| Location | US Access | EU Access | APAC Access | ME Access | Total Access |
|----------|-----------|-----------|-------------|-----------|--------------|
| Quintana Roo | ⭐⭐⭐⭐⭐ | ⭐⭐⭐ | ⭐⭐ | ⭐⭐ | 15/15 |
| Netherlands | ⭐⭐⭐ | ⭐⭐⭐⭐⭐ | ⭐⭐⭐ | ⭐⭐⭐ | 15/15 |
| Singapore | ⭐⭐⭐ | ⭐⭐⭐ | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐ | 15/15 |
| Dubai | ⭐⭐⭐ | ⭐⭐⭐⭐ | ⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ | 15/15 |
| Jamaica | ⭐⭐⭐⭐ | ⭐⭐⭐ | ⭐⭐ | ⭐⭐ | 14/15 |
| Baja California | ⭐⭐⭐⭐⭐ | ⭐⭐ | ⭐⭐ | ⭐ | 14/15 |

### Medical Infrastructure Comparison

| Location | Hospital Quality | Cardiac Capability | EMS Response | Total Medical |
|----------|-----------------|-------------------|--------------|---------------|
| Singapore | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ | 20/20 |
| Quintana Roo | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ | 19/20 |
| Dubai | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐ | 19/20 |
| Netherlands | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐ | ⭐⭐⭐⭐ | 18/20 |
| Thailand | ⭐⭐⭐⭐ | ⭐⭐⭐⭐ | ⭐⭐⭐⭐ | 18/20 |
| Portugal | ⭐⭐⭐⭐ | ⭐⭐⭐⭐ | ⭐⭐⭐⭐ | 17/20 |

---

## Strategic Recommendations

### Immediate Priorities (Next 12 Months)

1. **Secure Quintana Roo flagship property** - This is the foundation of the entire network
2. **Establish Portugal legal framework** - Engage counsel, begin licensing process
3. **Jamaica government relationships** - Build relationships for optimal positioning
4. **Baja site selection** - Identify properties in secure coastal areas

### Watch List (Monitor for Promotion)

| Location | Current Status | Trigger for Promotion |
|----------|---------------|----------------------|
| Australia | Psilocybin trials | National framework established |
| Canada | SAP exemptions | Broader access program |
| Germany | Cannabis model | Psychedelic framework discussion |
| UK | Research active | Regulatory reform signals |

### Deprioritized (Unlikely to Proceed)

| Location | Reason | Potential Reconsideration |
|----------|--------|---------------------------|
| Panama | Illegal, strict enforcement | Major legislative reform |
| Guatemala | Uncertain legal status | Clear legal pathway |
| Malaysia | Severe penalties | Impossible |
| Philippines | Death penalty for drugs | Impossible |

---

*Document Version: 1.0*
*Last Updated: January 2026*
*Classification: Strategic / Confidential*
